PARP Inhibitor Olaparib Causes No Potentiation of the Bleomycin Effect in VERO Cells, Even in the Presence of Pooled ATM, DNA-PK, and LigIV Inhibitors

por Perini, Valentina, Schacke, Michelle, Liddle, Pablo, Vilchez-Larrea, Salomé, Keszenman, Deborah J., Lafon-Hughes, Laura
Publicado 2020

PARP-1/2 Inhibitor Olaparib Prevents or Partially Reverts EMT Induced by TGF-β in NMuMG Cells

por Schacke, Michelle, Kumar, Janani, Colwell, Nicholas, Hermanson, Kole, Folle, Gustavo A., Nechaev, Sergei, Dhasarathy, Archana, Lafon-Hughes, Laura
Publicado 2019